| Ms Nina H Gaby, APRN-PMH | |
|
82 E View Ln Ste 3, Family Psychiatry Associates, Berlin, VT 05602-9516 | |
| (802) 225-1266 | |
| (802) 479-3548 |
| Full Name | Ms Nina H Gaby |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 34 Years |
| Location | 82 E View Ln Ste 3, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477850030 | NPI | - | NPPES |
| 1018814 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 101.0047020 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thomas Chittenden Health Center, Plc | 7012813322 | 15 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
As the national discussion of health care focuses on costs, a new study from North Carolina State University shows that it might be more accurate to think of health care spending as an investment that can spur economic growth.
Scios Inc. announced today that the landmark investigational study of NATRECOR (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically significant difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart failure re-hospitalizations and death during the first 30 days following treatment.
The Accelerated Cure Project for Multiple Sclerosis today launches iConquerMS, the nationwide initiative by and for individuals living with multiple sclerosis who recognize the power of their health data and insights and want to harness that power to fuel research.
› Verified 1 days ago
| Entity Name | Thomas Chittenden Health Center, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811099229 PECOS PAC ID: 7012813322 Enrollment ID: O20031209000188 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
As the national discussion of health care focuses on costs, a new study from North Carolina State University shows that it might be more accurate to think of health care spending as an investment that can spur economic growth.
Scios Inc. announced today that the landmark investigational study of NATRECOR (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically significant difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart failure re-hospitalizations and death during the first 30 days following treatment.
The Accelerated Cure Project for Multiple Sclerosis today launches iConquerMS, the nationwide initiative by and for individuals living with multiple sclerosis who recognize the power of their health data and insights and want to harness that power to fuel research.
› Verified 1 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
As the national discussion of health care focuses on costs, a new study from North Carolina State University shows that it might be more accurate to think of health care spending as an investment that can spur economic growth.
Scios Inc. announced today that the landmark investigational study of NATRECOR (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically significant difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart failure re-hospitalizations and death during the first 30 days following treatment.
The Accelerated Cure Project for Multiple Sclerosis today launches iConquerMS, the nationwide initiative by and for individuals living with multiple sclerosis who recognize the power of their health data and insights and want to harness that power to fuel research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nina H Gaby, APRN-PMH Po Box 547, Att: Cvmc Finance Dept, Barre, VT 05641-0547 Ph: (802) 225-1266 | Ms Nina H Gaby, APRN-PMH 82 E View Ln Ste 3, Family Psychiatry Associates, Berlin, VT 05602-9516 Ph: (802) 225-1266 |
News Archive
Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.
Generex Biotechnology Corporation today announced the results of the Company's annual meeting of stockholders held on July 28, 2010.At the annual meeting of stockholders, the following current directors were elected to serve on the Board of Directors until the next annual meeting of stockholders: Anna Gluskin, Rose Perri, Brian McGee, John Barratt, and Nola Masterson. Stockholders also ratified the appointment of MSCM LLP as the Company's independent registered public accounting firm for the year ending July 31, 2011.
As the national discussion of health care focuses on costs, a new study from North Carolina State University shows that it might be more accurate to think of health care spending as an investment that can spur economic growth.
Scios Inc. announced today that the landmark investigational study of NATRECOR (nesiritide) for the treatment of acutely decompensated heart failure (ADHF), ASCEND-HF, demonstrated no statistically significant difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart failure re-hospitalizations and death during the first 30 days following treatment.
The Accelerated Cure Project for Multiple Sclerosis today launches iConquerMS, the nationwide initiative by and for individuals living with multiple sclerosis who recognize the power of their health data and insights and want to harness that power to fuel research.
› Verified 1 days ago
Ms. Quincy Campbell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Rd, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
Christina Marie Tourangeau, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Road, Suite 200, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
David Alexander Segel, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Karen Gibbs, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 142 Woodridge Rd, Berlin, VT 05602 Phone: 802-371-4700 | |
Abbey Lynne Rouleau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Cvmc Palliative Care, 130 Fisher Road 2nd Floor, Berlin, VT 05602 Phone: 802-371-5372 | |
Margaret Jones, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-471-2100 | |
Morgan Lamson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Central Vermont Medical Center, 130 Fisher Road, Berlin, VT 05602 Phone: 802-371-4700 Fax: 802-371-4720 |